I support leadership teams in the healthcare and AI-related sectors as they navigate digital transformation and regulatory change. By combining AI policy expertise with rigorous data analytics, I help organizations streamline their innovation strategy and build a more resilient path to growth.

Artificial Intelligence Strategy, Implementation and Evaluation

• Strategic assessment of AI applications in healthcare, biotech/biopharma processes (focus on emerging economies), digital health, diagnostics, digital pathology, and health systems research and delivery

• Evaluation of AI-driven solutions in biosimilars, lab automation, and self-driving laboratory instrumentation

• Development of AI evaluation frameworks (technical performance, institutional integration, governance risks, and social impact)

• Bias, equity, and reliability assessment of algorithmic systems in healthcare contexts

Innovation Intelligence & technological foresight

• Patent landscape analysis and technological trajectory mapping in emerging AI-enabled medical domains

• Competitive intelligence and identification of emerging knowledge clusters

• Forecasting of innovation pathways in AI-healthcare convergence

• Strategic positioning in rapidly evolving AI-health ecosystems

R&D Impact & Investment Strategy

• Impact measurement of R&D investments in life sciences and health industries

• Evaluation of innovation capacity, manufacturing ecosystems, and technological upgrading—particularly in emerging economies

• Evidence-based support for public-private partnerships and global market expansion

• Assessment of translational research pipelines and commercialization pathways

Knowledge Systems & Network Analytics

• Mapping of scientific collaboration networks and innovation ecosystems

• Identification of strategic partnerships and research synergies

• Organizational analysis of knowledge production and interdisciplinary integration

Governance, Ethics & Regulatory Strategy

• Ethical and regulatory advisory for AI-enabled biomedical research and product development

• Responsible innovation frameworks aligned with international standards

• Institutional risk assessment in emerging AI-driven sectors

• Strategy development for compliance, transparency, and public trust